Constituent dispersion · breadth vs the index
XLV — Health Care Select Sector
Divergence over time — price vs breadth, by horizon
The hero read is the 1-month picture; here the same price↔breadth divergence across 1 week / 1 month / 1 quarter, computed over the 126-session history. A/D /name is net advancers-minus-decliners per covered constituent; % beating Δ and median−ETF Δ show how participation shifted. Price rising while those fall = the move is narrowing under the surface.
| Horizon | Price | A/D /name | % beating Δ | Median−ETF Δ | Read |
|---|---|---|---|---|---|
| 1 week | -1.98% | -0.51 | +0pp | -1.09pp | Confirming ↓ |
| 1 month | +4.67% | +1.58 | -5pp | -2.46pp | Confirming ↑ |
| 1 quarter | +14.51% | +4.41 | +17pp | +4.65pp | Confirming ↑ |
Over the last 126 sessions: price up +8.89%, breadth up (+1.25/name) · % beating 54→54 · median−ETF +2.46pp→+0.28pp.
Stocks above their moving average — participation breadth
Of the 59 covered constituents, the share trading above each simple moving average — the classic breadth gauge. A firm index price with a low %-above-MA is a narrow, top-heavy tape. As of 2026-08-28.
New highs & new lows — by horizon
How many of the 59 covered constituents closed today at a new high (or low) over each window, and the net. A shrinking net as the index holds up = fewer names leading.
| Horizon | New highs | New lows | Net |
|---|---|---|---|
| 5-Day | 4 (7%) | 24 (41%) | -20 |
| 1-Month | 1 (2%) | 2 (3%) | -1 |
| 3-Month | 1 (2%) | 1 (2%) | +0 |
| 6-Month | 0 (0%) | 0 (0%) | +0 |
| 52-Week | 0 (0%) | 0 (0%) | +0 |
| YTD | 0 (0%) | 0 (0%) | +0 |
Dispersion by window
| Window | ETF | Median | Median − ETF | Up / Down | Beat / Lag | ±1% band | Dispersion |
|---|---|---|---|---|---|---|---|
| 1d | -0.24% | -0.25% | +0.00pp | 24 / 35 | 29 / 30 | 33 of 59 | ±1.37% |
| 5d | -1.98% | -0.64% | +1.34pp | 21 / 38 | 42 / 17 | 15 of 59 | ±2.94% |
| 21d | +4.67% | +4.87% | +0.20pp | 45 / 13 | 31 / 27 | 10 of 58 | ±9.16% |
| YTD | +11.02% | +13.91% | +2.89pp | 43 / 15 | 33 / 25 | 0 of 58 | ±23.77% |
Median − ETF below zero means the typical name is lagging the cap-weighted index — the move is top-heavy. "Beat" counts constituents outperforming the ETF over the window. Dispersion is the cross-sectional standard deviation of constituent returns — high = a stock-picker's tape, low = pure beta.
What drove the move — contribution = weight × return
Today (1d)
- JNJ+0.85%+0.09pp
- SYK+2.66%+0.05pp
- ISRG+1.51%+0.04pp
- MDT+1.40%+0.03pp
- ABT+0.79%+0.02pp
- ABBV-1.03%-0.07pp
- GILD-2.14%-0.06pp
- TMO-1.35%-0.04pp
- MRK-0.80%-0.04pp
- AMGN-1.05%-0.04pp
This month (21d)
- MRK+14.30%+0.76pp
- JNJ+4.78%+0.5pp
- AMGN+11.55%+0.4pp
- PFE+12.24%+0.33pp
- GILD+10.97%+0.3pp
- UNH-6.77%-0.45pp
- CVS-11.56%-0.27pp
- SYK-4.99%-0.1pp
- ABBV-0.75%-0.05pp
- CI-3.05%-0.04pp
Each name's contribution = its index weight × its return — the percentage points it added to (green) or subtracted from (red) the ETF's move. Computed across covered names.
Leaders & laggards (21-day)
- VEEV+37.27%
- CRL+24.24%
- DXCM+21.84%
- RMD+15.23%
- BDX+14.55%
- DVA-24.36%
- PODD-12.40%
- CVS-11.56%
- ALGN-9.13%
- VTRS-8.00%
XLV — constituent leadership race
$100 in each covered XLV constituent at 2025-12-24, rebased to 100. Watch leadership change hands.
Each covered constituent started at $100 at the window open; the bars race by total return (top 12 shown). Decision-support, not investment advice.
Constituents — 59 covered · click a column to sort
| Symbol | Weight | Last | 1d | 5d | 21d | YTD | RS rank |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | 16.15% | 1174.61 | -0.13% | -6.44% | +1.70% | +9.48% | 29 |
| JNJ Johnson & Johnson | 10.44% | 268.04 | +0.85% | -0.32% | +4.78% | +30.21% | 47 |
| ABBV Abbvie Inc | 7.24% | 255.48 | -1.03% | -3.58% | -0.75% | +13.65% | 17 |
| UNH Unitedhealth Group | 6.62% | 392.95 | -0.53% | +0.73% | -6.77% | +19.96% | 9 |
| MRK Merck & Company | 5.28% | 148.35 | -0.80% | -2.75% | +14.30% | +41.98% | 90 |
| AMGN Amgen Inc | 3.44% | 432.42 | -1.05% | -1.57% | +11.55% | +33.03% | 83 |
| TMO Thermo Fisher Scientific | 3.17% | 622.18 | -1.35% | -1.13% | +7.87% | +7.48% | 72 |
| GILD Gilead Sciences Inc | 2.78% | 145.68 | -2.14% | -0.30% | +10.97% | +19.36% | 81 |
| ABT Abbott Laboratories | 2.76% | 112.47 | +0.79% | -3.58% | +6.50% | -9.21% | 69 |
| PFE Pfizer Inc | 2.68% | 27.96 | -0.21% | -0.39% | +12.24% | +14.17% | 84 |
| ISRG Intuitive Surg Inc | 2.63% | 372.60 | +1.51% | -1.64% | +5.56% | -34.21% | 59 |
| CVS CVS Corp | 2.33% | 93.06 | +0.15% | +0.04% | -11.56% | +19.27% | 3 |
| BMY Bristol-Myers Squibb Company | 2.09% | 66.58 | -0.55% | -0.64% | +2.65% | +26.18% | 36 |
| DHR Danaher Corp | 2.04% | 216.07 | +0.18% | -1.27% | +10.14% | -5.41% | 78 |
| VRTX Vertex Pharmaceutic | 2.03% | 541.69 | -1.07% | -1.16% | +12.45% | +19.48% | 86 |
| SYK Stryker Corp | 1.93% | 330.69 | +2.66% | +0.38% | -4.99% | -5.66% | 10 |
| MDT Medtronic Inc | 1.85% | 91.23 | +1.40% | -2.27% | +6.44% | -4.25% | 67 |
| MCK Mckesson Corp | 1.73% | 893.39 | +0.32% | +4.02% | +3.22% | +9.12% | 40 |
| ELV Elevance Health Inc | 1.60% | 394.43 | -1.17% | -1.53% | +4.79% | +13.21% | 48 |
| CI The Cigna Group | 1.41% | 278.88 | +0.44% | +0.49% | -3.05% | +2.47% | 12 |
| BSX Boston Scientific Corp | 1.25% | 46.84 | +0.36% | -7.01% | +1.83% | -50.88% | 33 |
| REGN Regeneron Pharmaceuticals | 1.11% | 794.19 | -1.67% | -4.78% | +7.56% | +3.02% | 71 |
| HCA Hca Holdings Inc | 1.09% | 417.82 | -0.36% | -2.65% | +5.57% | -10.37% | 60 |
| COR Cencora Inc | 0.99% | 322.03 | +0.25% | +1.25% | +3.14% | -4.27% | 38 |
| CAH Cardinal Health | 0.95% | 234.55 | -0.25% | +2.20% | +3.29% | +14.70% | 41 |
| EW Edwards Lifesciences Corp | 0.89% | 90.21 | +0.29% | +0.47% | +3.79% | +5.82% | 45 |
| HUM Humana Inc | 0.82% | 385.54 | -1.81% | +1.76% | +5.15% | +51.29% | 57 |
| IDXX Idexx Laboratories | 0.81% | 554.99 | +1.82% | -0.35% | -0.68% | -17.97% | 19 |
| BDX Becton Dickinson and Company | 0.75% | 189.52 | +0.74% | -1.29% | +14.55% | +25.01% | 91 |
| A Agilent Technologies | 0.66% | 153.84 | -2.44% | -3.25% | +10.91% | +13.52% | 79 |
| WAT Waters Corp | 0.63% | 414.69 | -1.56% | +0.97% | +9.04% | +9.18% | 74 |
| ZTS Zoetis Inc Cl A | 0.60% | 77.34 | +3.09% | -0.50% | +1.72% | -38.00% | 31 |
| IQV Iqvia Holdings Inc | 0.55% | 261.75 | -0.24% | +0.74% | +10.08% | +16.12% | 76 |
| CNC Centene Corp | 0.55% | 64.75 | -0.89% | -0.42% | +6.43% | +57.35% | 66 |
| GEHC GE Healthcare Technologies | 0.53% | 71.72 | -1.04% | -4.14% | +2.55% | -12.47% | 34 |
| BIIB Biogen Inc | 0.53% | 218.50 | -1.35% | +0.79% | +5.08% | +24.15% | 52 |
| DXCM Dexcom Inc | 0.52% | 90.82 | +1.71% | -1.65% | +21.84% | +36.84% | 95 |
| RMD Resmed Inc | 0.51% | 240.33 | +1.94% | +3.81% | +15.23% | +0.30% | 93 |
| VEEV Veeva Systems Inc | 0.43% | 276.69 | -1.93% | +11.61% | +37.27% | +23.95% | 98 |
| WST West Pharmaceutical Services | 0.43% | 337.47 | -2.49% | -4.42% | -0.62% | +22.86% | 21 |
| MTD Mettler-Toledo International | 0.41% | 1398.58 | -0.63% | +0.24% | +1.30% | +0.31% | 28 |
| DGX Quest Diagnostics Inc | 0.40% | 242.76 | -0.76% | -0.67% | +3.61% | +41.14% | 43 |
| LH Laboratory Corp of America | 0.40% | 335.11 | -0.21% | -0.15% | +6.21% | +34.28% | 62 |
| STE Steris Corp | 0.37% | 233.78 | +0.35% | -1.74% | +1.11% | -7.55% | 24 |
| VTRS Viatris Inc | 0.34% | 16.34 | -3.26% | +0.12% | -8.00% | +33.34% | 7 |
| INCY Incyte Corp | 0.33% | 124.37 | -2.64% | -2.69% | +1.12% | +25.92% | 26 |
| ZBH Zimmer Biomet Holdings | 0.32% | 100.91 | +1.44% | -0.07% | +6.27% | +12.53% | 64 |
| MRNA Moderna Inc | 0.31% | 137.99 | -3.35% | -4.92% | — | — | — |
| COO Cooper Companies | 0.24% | 71.17 | +0.30% | -6.63% | -2.04% | -13.16% | 16 |
| ALGN Align Technology | 0.21% | 157.58 | -0.79% | -3.06% | -9.13% | +0.92% | 5 |
| SOLV Solventum Corporation | 0.21% | 91.12 | +0.21% | +1.73% | +4.95% | +14.99% | 50 |
| RVTY Revvity Inc | 0.20% | 128.80 | -0.70% | +3.25% | +13.44% | +33.31% | 88 |
| BAX Baxter International | 0.19% | 26.13 | +0.77% | -0.76% | -2.32% | +36.87% | 14 |
| PODD Insulet Corp | 0.19% | 145.13 | +1.20% | -2.05% | -12.40% | -48.94% | 2 |
| CRL Charles River Laboratories | 0.17% | 291.50 | -1.66% | -1.25% | +24.24% | +46.13% | 97 |
| TECH Bio-Techne Corp | 0.15% | 72.35 | -0.17% | +0.15% | +0.44% | +23.42% | 22 |
| HSIC Henry Schein Inc | 0.15% | 89.52 | -0.84% | +1.15% | +5.11% | +18.44% | 53 |
| UHS Universal Health Services | 0.15% | 171.66 | -0.53% | -3.16% | +5.13% | -21.19% | 55 |
| DVA Davita Healthcare Partners | 0.13% | 180.68 | +1.01% | +3.95% | -24.36% | +59.04% | 0 |
RS rank = the constituent's 21-day return percentile within the index (100 = strongest of the covered names). Weight is the index weight; returns use adjusted closes. Default sort: weight.
Other ETFs & indices
Dispersion is computed across the constituents we cover in our data lake (see coverage badge). Decision-support, not investment advice.
FAQ · from the current data
XLV dispersion — data Q&A
Is XLV's move broad or carried by a few names (21 sessions)?
As of 2026-08-28: over 21 sessions the fund returned +4.67% while its median constituent returned +4.87% — a dispersion of 9.16 pp; 53% of 58 members beat the fund. Broad advance - breadth is rising with price.
How did XLV's members trade in the last session?
As of 2026-08-28: fund -0.24%, median member -0.25%, 24 advancers vs 35 decliners.
What does the dispersion page for XLV measure?
It splits the fund into its members: the fund's own return against the median constituent, how many members beat the fund, advancers vs decliners, and a cumulative advance/decline line that tends to lead price. A firm fund price with a weak median and a falling A/D line is a narrow, top-heavy tape; a broad move shows the median keeping up. 59 constituents covered, re-baked nightly from the Closelook lake.
Is this investment advice?
No — a data surface in an investment research diary. It describes breadth inside a fund; it makes no recommendation.